Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X
Analysis

Taking aim with nanotechnology

One of the key challenges of drug delivery is ensuring the right dose reaches the target without damaging healthy cells. Richard Moore of the Institute of Nanotechnology and inventor, entrepreneur and former MIT researcher Geoffrey von Maltzahn tell Elly Earls why downsizing drug delivery to the nanoscale helps scientists pull off this balancing act.

Go Top